ADMA.NASDAQAdma Biologics, INC

Form 4: ADMA Biologics CEO Adam Grossman Reports Stock Transactions

Sentiment:

SEC Form 4 Filing

📋All filings for Adma Biologics, INC
🔒Login to Follow

Adam Grossman, President and CEO of ADMA Biologics, reports the withholding of shares to cover tax obligations upon the vesting of restricted stock units.

Summary

  • On February 25, 2025, Adam Grossman, the President and CEO of ADMA Biologics, had 18,018 common stock shares withheld at a price of $15.44 to cover tax obligations related to vesting restricted stock units.
  • Following this transaction, Grossman directly owns 2,208,668 shares of ADMA Biologics common stock.
  • On February 26, 2025, an additional 54,867 shares were withheld at $15.78 for the same reason, resulting in direct ownership of 2,153,801 shares.
  • Grossman also indirectly owns 1,143,426 shares through Areth, LLC and 580,957 shares through Hariden, LLC.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions related to executive compensation. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the executive's holdings and transactions.

Stakeholder Impact

  • The transactions have a minor impact on shareholders as they reflect routine tax-related stock withholding.

Key Dates

DateDescription
02/25/202518,018 shares withheld for tax obligations at $15.44 per share.
02/26/202554,867 shares withheld for tax obligations at $15.78 per share.
02/27/2025Date of signature for the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.